Sort
17,828 grants matching “crispr”
Basic Investigation and Translational Applications Concerning the Cell and Molecular Biology of Blood and Vascular Cells
$966,838Peter J Newman · Versiti Wisconsin, Inc. · R35 · FY2024 · HL
Genetic mechanisms of type 1 diabetes risk in stress-induced pancreatic islets
$965,894Kyle Jeffrie Gaulton · University Of California, San Diego · R01 · FY2019 · DK
Targeting the MYC Pathway for the Treatment of Cancer
$965,767Dean W Felsher · Stanford University · R35 · FY2025 · CA
Differential function and tumor vulnerabilities revealed by RAS membrane trafficking
$965,424Mark Reid Philips · New York University School Of Medicine · R35 · FY2024 · CA
Identifying Metabolic Dependencies of Pancreatic Cancers
$964,796Alec Kimmelman · New York University School Of Medicine · R35 · FY2024 · CA
Spatial functional genomics to identify regulators of the tumor microenvironment and cancer immunity
$964,277Brian D Brown · Icahn School Of Medicine At Mount Sinai · U01 · FY2024 · CA
Validation of the Genetically Malleable Oncopig Hepatocellular carcinoma (HCC) Model for Targeted Therapeutic Development
$964,276Kyle Schachtschneider · Sus Clinicals, Inc. · R44 · FY2023 · CA
Single-Cell Transcriptomics of Non-Activated Latently Infected T cells Isolated from HIV+ Drug Users
$963,778Melanie Maria Ott · J. David Gladstone Institutes · R33 · FY2022 · DA
Development and implementation of multiplex methods to understand the biology and heterogeneity of patient-derived cancer models
$963,693William C Hahn · Dana-Farber Cancer Inst · U01 · FY2022 · CA
Targeting the MYC Pathway for the Treatment of Cancer
$963,300Dean W Felsher · Stanford University · R35 · FY2021 · CA
Development and implementation of multiplex methods to understand the biology and heterogeneity of patient-derived cancer models
$963,150William C Hahn · Dana-Farber Cancer Inst · U01 · FY2021 · CA
New Paradigms for Targeting Truncal Driver Mutations
$962,850William G Kaelin · Dana-Farber Cancer Inst · R35 · FY2022 · CA
Targeting the MYC Pathway for the Treatment of Cancer
$962,720Dean W Felsher · Stanford University · R35 · FY2020 · CA
Differential function and tumor vulnerabilities revealed by RAS membrane trafficking
$962,665Mark Reid Philips · New York University School Of Medicine · R35 · FY2023 · CA
Airway epithelial cell gene regulation: new mechanisms and therapeutic strategies
$961,617David J Erle · University Of California, San Francisco · R35 · FY2019 · HL
Deregulation of long noncoding RNAs in cancer
$961,547Nadya M Dimitrova · Yale University · R01 · FY2025 · CA
Whole genome sequencing consortium on Frontotemporal dementia with underlying TDP-43 pathology
$961,469Rosa Rademakers · Mayo Clinic Jacksonville · UG3 · FY2017 · NS
Hearing regeneration in zebrafish
$961,278Shawn M Burgess · National Human Genome Research Institute · ZIA · FY2018 · HG
Zebrafish targeted mutagenesis and functional genomics
$961,278Shawn M Burgess · National Human Genome Research Institute · ZIA · FY2018 · HG
Genetic mechanisms of type 1 diabetes risk in stress-induced pancreatic islets
$960,228Kyle Jeffrie Gaulton · University Of California, San Diego · R01 · FY2021 · DK
Genetic mechanisms of type 1 diabetes risk in stress-induced pancreatic islets
$960,228Kyle Jeffrie Gaulton · University Of California, San Diego · R01 · FY2022 · DK
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis
$959,618Laura D Attardi · Stanford University · R35 · FY2025 · CA
Short-term and long-term effects of methamphetamine exposure on residual viral transcription during treated HIV disease
$958,404Sulggi Angela Lee · University Of California, San Francisco · R61 · FY2019 · DA
Genome instability in cancer: telomeres and DNA repair
$957,507Titia De Lange · Rockefeller University · R35 · FY2024 · CA
Predicting Cancer Cell Response to Endogenous and Exogenous Perturbations at the Single Cell Level
$957,321Andrea Califano · Columbia University Health Sciences · R35 · FY2023 · CA